Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Siren, L.L.C.
Form 13F · Q2 2026

Siren, L.L.C.

CIK 2005245Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$4.9B
Reported book value
119
Positions
8
Quarters on record
Top 50
Positions

Siren, L.L.C. — holdings

Top 50 positions of 119, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SRRK Scholar Rock Hldg Corp9.6M−11.5%$527M10.7%
2KYMR Kymera Therapeutics Inc2.9M−7.9%$337M6.8%
3ERAS Erasca Inc11.4M+1.4%$209M4.2%
4MANE Veradermics Inc1.7M+10.0%$204M4.1%
5TNGX Tango Therapeutics Inc6.2M+9.2%$193M3.9%
6RVMD Revolution Medicines Inc900,000−19.0%$169M3.4%
7BCAX Bicara Therapeutics Inc5.6M−3.4%$166M3.4%
8ARWR Arrowhead Pharmaceuticals In1.7M+6.2%$140M2.8%
9ONC Beone Medicines Ltd465,000+0.0%$133M2.7%
10EWTX Edgewise Therapeutics Inc3.2M−28.1%$129M2.6%
11RYTM Rhythm Pharmaceuticals Inc1.1M+56.6%$126M2.6%
12LXRX Lexicon Pharmaceuticals Inc44.3M+0.0%$106M2.2%
13ELVN Enliven Therapeutics Inc1.8M+137.8%$90M1.8%
14SYRE Spyre Therapeutics Inc968,598+18.3%$86M1.7%
15PBLS Parabilis Medicines Inc3.0M—$82M1.7%
16XENE Xenon Pharmaceuticals Inc1.3M+0.0%$80M1.6%
17SLDB Solid Biosciences Inc7.7M+0.0%$77M1.6%
18ABIVAX SA Abivax Sa576,000—$77M1.6%
19COAG Hemab Therapeutics Hldgs Inc2.1M—$77M1.6%
20RCUS Arcus Biosciences Inc2.4M−19.5%$75M1.5%
21COGT Cogent Biosciences Inc1.9M+8.8%$72M1.5%
22RLAY Relay Therapeutics Inc3.6M—$68M1.4%
23TSHA Taysha Gene Therapies Inc9.8M+11.5%$67M1.4%
24DFTX Definium Therapeutics Inc1.4M+54.4%$67M1.4%
25STOK Stoke Therapeutics Inc2.0M+0.0%$65M1.3%
26IRON Disc Medicine Inc888,401−10.1%$65M1.3%
27CYTK Cytokinetics Inc758,952+23.6%$65M1.3%
28SEPN Septerna Inc1.9M−5.0%$64M1.3%
29OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc4.9M+2.1%$61M1.2%
30CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.4M−25.4%$53M1.1%
31KLRA Kailera Therapeutics Inc2.2M—$49M1.0%
32DYN Dyne Therapeutics Inc2.1M−4.5%$47M1.0%
33GPCR Structure Therapeutics Inc872,967−34.3%$47M0.9%
34TBLA Taboola.Com Ltd8.4M−15.5%$42M0.9%
35PVLA Palvella Therapeutics Inc Ne257,485+0.0%$39M0.8%
36SLN Silence Therapeutics Plc3.3M+13.7%$36M0.7%
37DNLI Denali Therapeutics Inc1.4M+0.0%$36M0.7%
38RELY Remitly Global Inc1.5M+0.0%$35M0.7%
39CGEM Cullinan Therapeutics Inc1.9M+58.7%$34M0.7%
40CAPITAL ONE FINL CORP Capital One Finl Corp171,615—$34M0.7%
41TRVI Trevi Therapeutics Inc1.8M+0.0%$33M0.7%
42ORIC Oric Pharmaceuticals Inc3.0M+0.0%$32M0.7%
43GOOGL Alphabet Inc90,000+37.0%$32M0.7%
44DBVT Dbv Technologies S A1.9M+0.0%$30M0.6%
45ABSI Absci Corporation2.5M+37.5%$29M0.6%
46SION Sionna Therapeutics Inc610,515+103.5%$27M0.5%
47RAPP Rapport Therapeutics Inc641,469+0.0%$27M0.5%
48AMLX Amylyx Pharmaceuticals Inc1.5M+20.4%$27M0.5%
49ANNX Annexon Inc4.5M+12.6%$25M0.5%
50MNPR Monopar Therapeutics Inc270,118+0.0%$25M0.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.